For Advisers: Assessing Risk Tolerance

Christel Deskins

This has been a rocky year for investors and 2020 still has several months to go. The economic fallout from COVID-19 has impacted the stock market in a big way. We’ve seen the market reach all-time highs in February only to drop precipitously into March. The markets have rebounded nicely […]

This has been a rocky year for investors and 2020 still has several months to go. The economic fallout from COVID-19 has impacted the stock market in a big way. We’ve seen the market reach all-time highs in February only to drop precipitously into March.

The markets have rebounded nicely since then. However, it’s been a bumpy ride, and nobody knows what the future holds over the next few months with the continued virus issues and the election coming up in November.

You have probably done a risk tolerance assessment of your clients at one point or another. Given all that’s happened, this is a good time to assess or re-assess your client’s risk tolerance.

Reacting to Market Volatility

An informal insight into a client’s risk tolerance is how they react to volatile periods in the stock market. Have they generally been calm during market volatility in the past, but have been more concerned about the volatility this year in the wake of the COVID-19 pandemic? Perhaps their personal situation has changed during the pandemic due to a job loss or a furlough.

Even clients who may seem calm outwardly may be feeling stressed about the volatility of the markets and the impact of the pandemic on the economy. Every client is a bit different in how they deal with stress. If you aren’t sure how your client is feeling about market volatility, ask them. Even clients who seem the most immune to feeling anxiety regarding their investments might become more affected by concerns over their investments over time.

Source Article

Next Post

Pain Management Drugs Market to Garner USD 85.54 Billion by 2027: AMR

Rise in incidences of chronic diseases, surge in geriatric populations, and favorable regulatory scenarios drive the growth of the global pain management drugs market. The market across Asia-Pacific is anticipated to manifest the highest CAGR of 4.5% during the forecast period. Demand for pain management drugs is anticipated to rise […]